JP
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Recommandations pour la prévention, le diagnostic et la thérapie des addictions à l’âge avancé | Revue médicale suisse | 2022 | 19 | 9 | |||
Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies | Frontiers in aging neuroscience | 2021 | 62 | 49 | |||
Relationship between delirium and depression in old age | Swiss archives of neurology, psychiatry and psychotherapy | 2021 | 223 | 89 | |||
Empfehlungen für die Prävention, Diagnostik und Therapie der Abhängigkeitserkrankungen im Alter | Praxis | 2021 | 9 | 0 | |||
Replication study of plasma proteins relating to Alzheimer's pathology | Alzheimer's & dementia | 2021 | 152 | 56 | |||
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort | Alzheimer's & dementia | 2019 | 433 | 167 | |||
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay | Alzheimer's & Dementia | 2019 | 278 | 198 | |||
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort | Alzheimer's & Dementia | 2019 | 270 | 165 | |||
Preoperative Depression and Plasma Cortisol Levels as Predictors of Delirium after Cardiac Surgery | Dementia and geriatric cognitive disorders | 2019 | 138 | 0 | |||
The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics | Alzheimer's Research and Therapy | 2018 | 455 | 0 | |||
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease | Alzheimer's & Dementia | 2018 | 382 | 3 | |||
Do diurnal cortisol levels mediate the association between sleep disturbances and cognitive impairment? | Neurobiology of Aging | 2018 | 417 | 0 | |||
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study | Alzheimer's Research and Therapy | 2018 | 427 | 197 | |||
Recommendations of Swiss Memory Clinics for the Diagnosis of Dementia | Praxis (Bern 1994) | 2018 | 494 | 0 | |||
A global HILIC-MS approach to measure polar human cerebrospinal fluid metabolome: Exploring gender-associated variation in a cohort of elderly cognitively healthy subjects | Analytica Chimica Acta | 2018 | 425 | 1 | |||
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia | JAMA Psychiatry | 2018 | 491 | 344 | |||
The Effects of Hand Massage on Stress and Agitation Among People with Dementia in a Hospital Setting: A Pilot Study | Applied Psychophysiology and Biofeedback | 2018 | 431 | 203 | |||
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization | Journal of Alzheimer's Disease | 2017 | 734 | 0 | |||
Neuroticism, depression, and anxiety traits exacerbate the state of cognitive impairment and hippocampal vulnerability to Alzheimer's disease | Alzheimer's & Dementia | 2017 | 375 | 0 | |||
Personality, Cortisol, and Cognition in Non-demented Elderly Subjects: Results from a Population-Based Study | Frontiers in Aging Neuroscience | 2017 | 384 | 188 | |||
Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia | Journal of Alzheimer's Disease | 2017 | 428 | 0 | |||
ICP-MS/MS-Based Ionomics: A Validated Methodology to Investigate the Biological Variability of the Human Ionome | Journal of Proteome Research | 2017 | 396 | 1 | |||
Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults | Journal of Alzheimer's Disease | 2017 | 415 | 0 | |||
Relations between personality changes and cerebrospinal fluid biomarkers of Alzheimer's disease pathology | Journal of Psychiatric Research | 2017 | 742 | 1 | |||
Life events, salivary cortisol, and cognitive performance in nondemented subjects: a population-based study | Neurobiology of Aging | 2017 | 411 | 2 | |||
One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond | Alzheimer's Research and Therapy | 2017 | 493 | 189 | |||
Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia | Experimental Gerontology | 2017 | 387 | 0 | |||
Sleep characteristics and cognitive impairment in the general population: The HypnoLaus study | Neurology | 2017 | 1,033 | 1 | |||
Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults | Brain, Behavior and Immunity | 2017 | 407 | 0 | |||
Interaction between personality traits and cerebrospinal fluid biomarkers of Alzheimer's disease pathology modulates cognitive performance | Alzheimer's Research and Therapy | 2017 | 398 | 164 | |||
Response to a letter to the editor: sleep disturbance as a stressor event in elderly's life | Neurobiology of Aging | 2017 | 380 | 0 | |||
L'agitation chez les personnes atteintes de démence : examen de la portée des connaissances et mise en perspective du phénomène selon la théorie du confort et le concept de l'attachement | Recherche en soins infirmiers | 2016 | 484 | 0 | |||
Les biomarqueurs du liquide céphalorachidien dans la maladie d'Alzheimer en pratique clinique courante | Revue médicale suisse | 2016 | 414 | 191 | |||
Recommandations for prevention, diagnostic and therapy of delirium in the elderly | Praxis (Bern 1994) | 2016 | 382 | 0 | |||
Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta | Journal of Neurochemistry | 2016 | 409 | 0 | |||
Behavioral and psychological symptoms and cognitive decline in patients with amnestic MCI and mild AD: a two-year follow-up study | International Psychogeriatrics | 2015 | 403 | 0 | |||
Delirium in the elderly: Current problems with increasing geriatric age | Indian Journal of Medical Research | 2015 | 389 | 299 | |||
CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study | Alzheimer's and Dementia | 2015 | 383 | 0 | |||
Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type | Neurobiology of Aging | 2015 | 383 | 0 | |||
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis | JAMA | 2015 | 557 | 2 | |||
Empfehlungen zur Diagnostik und Therapie der behavioralen und psychologischen Symptome der Demenz (BPSD) | Praxis (Bern 1994) | 2014 | 522 | 0 | |||
Subjective cognitive decline in patients with mild cognitive impairment and healthy older adults: association with personality traits | Geriatrics and Gerontology International | 2014 | 358 | 2 | |||
SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease | Human Molecular Genetics | 2014 | 354 | 1 | |||
Predisposing and precipitating factors of delirium after cardiac surgery: a prospective observational cohort study | Annals of Surgery | 2013 | 379 | 0 | |||
The evolution of personality in patients with mild cognitive impairment | Dementia and Geriatric Cognitive Disorders | 2013 | 387 | 0 | |||
Delirium and cognitive decline: more than a coincidence | Current Opinion in Neurology | 2013 | 313 | 0 | |||
Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's disease | Biochemical Pharmacology | 2013 | 389 | 0 | |||
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial | The Lancet Neurology | 2013 | 315 | 0 |